Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation

[1]  S. Möhlenkamp,et al.  Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation , 2011, Circulation research.

[2]  G. Heusch,et al.  C-reactive protein: just a biomarker of inflammation or a pathophysiological player in myocardial function and morphology? , 2011, Hypertension.

[3]  K. Yoon,et al.  An Immunoprotective Privilege of Corneal Epithelial Stem Cells Against Th17 Inflammatory Stress by Producing Glial Cell‐Derived Neurotrophic Factor , 2010, Stem cells.

[4]  M. Penn.  SDF-1:CXCR4 axis is fundamental for tissue preservation and repair. , 2010, The American journal of pathology.

[5]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[6]  A. Xiang,et al.  Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.

[7]  Ke Chen,et al.  CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. , 2010, Experimental cell research.

[8]  D. Meldrum,et al.  ABLATION OF TNF-&agr; RECEPTORS INFLUENCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION AGAINST ISCHEMIA , 2010, Shock.

[9]  G. Heusch,et al.  TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. , 2010, Pharmacology & therapeutics.

[10]  D. Meldrum,et al.  Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. , 2010, Surgery.

[11]  E. Chavakis,et al.  Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice , 2010, Basic Research in Cardiology.

[12]  Meijing Wang,et al.  TNF RECEPTOR 2, NOT TNF RECEPTOR 1, ENHANCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION FOLLOWING ACUTE ISCHEMIA , 2010, Shock.

[13]  C. Vrints,et al.  Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure , 2010, Basic Research in Cardiology.

[14]  Stefanie Dimmeler,et al.  Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell Therapy: Role of Cardiovascular Lineage Commitment , 2010, Circulation.

[15]  S. Grieve,et al.  Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. , 2010, Circulation. Heart failure.

[16]  D. Meldrum,et al.  Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. , 2010, American journal of physiology. Heart and circulatory physiology.

[17]  R. Bolli,et al.  Hepatocyte growth factor/Met gene transfer in cardiac stem cells—potential for cardiac repair , 2010, Basic Research in Cardiology.

[18]  M. Goumans,et al.  Active Wnt signaling in response to cardiac injury , 2010, Basic Research in Cardiology.

[19]  S. Raiden,et al.  Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile , 2010, PloS one.

[20]  Choon-Sik Park,et al.  Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis , 2010, Respiratory research.

[21]  W. Franz,et al.  Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy , 2010, Expert opinion on biological therapy.

[22]  A. Lindahl,et al.  C-kit+ CD45− cells found in the adult human heart represent a population of endothelial progenitor cells , 2010, Basic Research in Cardiology.

[23]  Xiangbin Xu,et al.  Direct relationship between levels of TNF-α expression and endothelial dysfunction in reperfusion injury , 2010, Basic Research in Cardiology.

[24]  C. Thiemermann,et al.  Mesenchymal Stromal Cells: Current Understanding and Clinical Status , 2009, Stem cells.

[25]  R. Ferrari,et al.  TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL , 2010, Cellular and Molecular Life Sciences.

[26]  L. Hsu,et al.  Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. , 2009, Singapore medical journal.

[27]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[28]  M. Daemen,et al.  Mouse strain determines the outcome of wound healing after myocardial infarction. , 2009, Cardiovascular research.

[29]  M. Penn.  Importance of the SDF-1:CXCR4 axis in myocardial repair. , 2009, Circulation research.

[30]  L. Popescu,et al.  Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches , 2009, Journal of cellular and molecular medicine.

[31]  Hong Jiang,et al.  Stem cell engineering for treatment of heart diseases: Potentials and challenges , 2009, Cell biology international.

[32]  C. Toma,et al.  Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature: In Vivo Observations of Cell Kinetics , 2009, Circulation research.

[33]  Z. Bagi,et al.  Where have all the stem cells gone? , 2009, Circulation research.

[34]  Jong Chun Park,et al.  TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. , 2009, Frontiers in bioscience.

[35]  M. Isobe,et al.  Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. , 2009, Cardiovascular research.

[36]  S. Belmadani,et al.  Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. , 2008, American journal of physiology. Heart and circulatory physiology.

[37]  N. Bishopric.  Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord. , 2008, Circulation research.

[38]  N. Rosenthal,et al.  Interleukin-10 From Transplanted Bone Marrow Mononuclear Cells Contributes to Cardiac Protection After Myocardial Infarction , 2008, Circulation research.

[39]  H. Lodish,et al.  Cytokines regulating hematopoietic stem cell function , 2008, Current opinion in hematology.

[40]  G. Gerosa,et al.  Different Cardiovascular Potential of Adult- and Fetal-Type Mesenchymal Stem Cells in a Rat Model of Heart Cryoinjury , 2008, Cell transplantation.

[41]  S. Fazel,et al.  Microsomal Prostaglandin E2 Synthase-1 Deletion Leads to Adverse Left Ventricular Remodeling After Myocardial Infarction , 2008, Circulation.

[42]  P. Doevendans,et al.  Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. , 2008, Current pharmaceutical design.

[43]  P. Harding,et al.  Reduced Cardiac Remodeling and Function in Cardiac-Specific EP4 Receptor Knockout Mice With Myocardial Infarction , 2008, Hypertension.

[44]  T. Bartsch,et al.  Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction , 2007, European journal of clinical investigation.

[45]  Ahmad Y. Sheikh,et al.  Differentiation, Survival, and Function of Embryonic Stem Cell–Derived Endothelial Cells for Ischemic Heart Disease , 2007, Circulation.

[46]  R. Schwinger,et al.  Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction , 2007, Clinical Research in Cardiology.

[47]  J. Hare,et al.  Advances in cell-based therapy for structural heart disease. , 2007, Progress in cardiovascular diseases.

[48]  J. García-Sancho,et al.  Cardiac repair by stem cells , 2007, Cell Death and Differentiation.

[49]  D. Goukassian,et al.  Neovascularization Receptor P75 Is Required in Ischemia-induced Α Tumor Necrosis Factor- Tumor Necrosis Factor-␣ Receptor P75 Is Required in Ischemia-induced Neovascularization , 2007 .

[50]  J. Vinten-johansen,et al.  Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. , 2007, Hematology/oncology clinics of North America.

[51]  D. Goukassian,et al.  Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. , 2007, Circulation.

[52]  D. Link,et al.  Cytokines and hematopoietic stem cell mobilization , 2006, Journal of cellular biochemistry.

[53]  D. Shum-Tim,et al.  Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. , 2006, The Journal of thoracic and cardiovascular surgery.

[54]  Roberto Bolli,et al.  Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology , 2006, Circulation.

[55]  Yong-Fu Xiao,et al.  Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis , 2006, Pflügers Archiv.

[56]  P. Anversa,et al.  Cardiac stem cells and mechanisms of myocardial regeneration. , 2005, Physiological reviews.

[57]  M. Ratajczak,et al.  CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion , 2003, Journal of Molecular Histology.

[58]  L. Tavazzi,et al.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.

[59]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[60]  M. Tendera,et al.  Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction , 2004, Circulation.

[61]  M. Yacoub,et al.  Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[63]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[64]  K. Chien.  Stem cells: Lost in translation , 2004, Nature.

[65]  M. Greeley,et al.  Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs , 2004, The Lancet.

[66]  O. Dewald,et al.  Inflammatory mechanisms in myocardial infarction. , 2003, Current drug targets. Inflammation and allergy.

[67]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[68]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[69]  H. Schäfers,et al.  Cardiomyocytes of Noncardiac Origin in Myocardial Biopsies of Human Transplanted Hearts , 2002, Circulation.

[70]  G. Spangrude,et al.  Chimerism of the transplanted heart. , 2002, The New England journal of medicine.

[71]  J. Saffitz,et al.  Evidence for Cardiomyocyte Repopulation by Extracardiac Progenitors in Transplanted Human Hearts , 2002, Circulation research.

[72]  K. Ohta,et al.  Regulation of Chemokine Receptor Expression in Eosinophils , 2001, International Archives of Allergy and Immunology.

[73]  L. Becker,et al.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[74]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[75]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[76]  R. Guyton,et al.  Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. , 2000, The Journal of surgical research.

[77]  T. Issekutz,et al.  Human Mast Cells Transmigrate Through Human Umbilical Vein Endothelial Monolayers and Selectively Produce IL-8 in Response to Stromal Cell-Derived Factor-1α1 , 2000, The Journal of Immunology.

[78]  C M Gibson,et al.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.

[79]  M. Jutila,et al.  Effects of Continuous Exposure to Stromal Cell-Derived Factor-1α on T Cell Rolling and Tight Adhesion to Monolayers of Activated Endothelial Cells1 , 2000, The Journal of Immunology.

[80]  S. Sozzani,et al.  Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. , 2000, Journal of the National Cancer Institute.

[81]  J. Mehta,et al.  Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction , 1999 .

[82]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[83]  J. Mehta,et al.  Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. , 1999, American heart journal.

[84]  M. Gobbi,et al.  Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. , 1997, Journal of immunology.

[85]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[86]  M. Soonpaa,et al.  Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. , 1997, The American journal of physiology.

[87]  C. Smith,et al.  Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody. , 1996, The American journal of pathology.

[88]  W. Baumgartner,et al.  Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. , 1993, The American journal of pathology.

[89]  D. Royston,et al.  Reperfusion injury. , 1991, Critical care nursing clinics of North America.

[90]  E. Elson,et al.  Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. , 1989, Science.

[91]  J. Croese,et al.  Animal model of human disease. Multiple myeloma. , 1988, The American journal of pathology.

[92]  G. Schmid-Schönbein,et al.  Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. , 1986, The American journal of physiology.

[93]  J. Radl,et al.  Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. , 1978, Clinical and experimental immunology.

[94]  Lofland Hb.  Animal model of human disease. , 1975, The American journal of pathology.